Top news of the week: 27.05.2022.
Career And Jobs
Samsung to Invest $356 Billion into Chipmaking, Biopharma
Most of Samsung's investment will be in South Korea, and it expects to create 80,000 new jobs through 2026, or about 16,000 positions annually.
Vir Biotech, Wuxi Biologics End COVID-19 Antibody Collaboration
Vir Biotechnology terminated a two-year-old COVID-19-related antibody collaboration with Wuxi Biologics that included sotrovimab, which lost EUA in the U.S. earlier this year.
Intellia Weighs in on How to Identify and Avoid Scam Job Offers
BioSpace sat down with Maritza Gamboa, the Associate Director of Talent Acquisition at Intellia Therapeutics, to find out how to identify and avoid scam job offers.
BioSpace Introduces Diversity in Life Sciences Content Series
This summer, BioSpace will release a series of reports looking at the current state of diversity and inclusion in the life sciences.
Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein
Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein Ellipses Pharma granted exclusive global rights to ...
MassBio® Announces a Relaunch of its Young Professional Program as Part of their Membership Offerings
May 24, 2022 (CAMBRIDGE, MA) – Today, the Massachusetts Biotechnology Council (MassBio®) announced it is relaunching its young professionals program for member companies, providing ...
Money on the Move: Biotechs Target Cancers, Dermatology and Strokes
Private investors, governmental institutions and longtime life sciences investors provided funding to develop therapies for cancers, dermatological problems and acute ischemic strokes.
From Bench to Boardroom, PhD-Wielding Founders Buck Tradition
Today, scientist-founders are likely to remain in charge, shepherding the companies they founded to the next iteration. BioSpace spoke with one such founder, Mammoth Biosciences' Trevor ...